Search company, investor...
Kalion company logo


Founded Year



Convertible Note - II | Alive

Total Raised


Last Raised

$640K | 7 mos ago

About Kalion

Kalion is an industrial biotechnology manufacturer of high-purity glucaric acid and glucuronic acid for applications such as industrial water treatment, new materials, and pharmaceuticals. The company was founded in 2010 and is based in Milton, Massachusetts.

Headquarters Location

92 Elm Street

Milton, Massachusetts, 02186,

United States


Missing: Kalion's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Kalion's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Kalion

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kalion is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Kalion News

Kalion wins DOE grant to advance glucaric acid

Nov 3, 2020

Kalion wins DOE grant to advance glucaric acid “Partnering with the exceptional talents and capabilities in the Agile BioFoundry will allow us to greatly advance the industrial bioeconomy and create a more sustainable future for all Americans,” says Darcy Prather, CEO of Kalion. Applications for glucaric acid include water treatment, polymers & textiles, coatings, detergents, and pharmaceuticals. Your email: We’re joined by Clariant and Chemtex to share their perspective on 2G technology and 2G / 1G integration. How does it work? What are the potential rewards? We're joined by Clariant’s Paolo Corvo and Chemtex’s Jeff Taylor, and we also shared some up-to-the-minute fresh video from Clariant’s first commercial cellulosic ethanol project in Podari, Romania. Stream it here. Today. Cannabinoids. Is there an opportunity for pure, consistent product at huge scale with miniscule cost of goods via commercial-scale fermentation for a market that people are projecting will shortly top $100B? today by Amyris Chief Operating Officer Eduardo Alvarez and Sr. VP, R&D Sunil Chandran, and two members of the Due Diligence Wolfpack, David Dodds and Joel Stone. Stream it here. Today, DME for heavy transport - the brave new world of DME fuels and the companies bringing this new technology forward. Our guests today are Rebecca Boudreaux, CEO of Oberon Fuels and Mike Stivala CEO of Suburban Propane which just acquired a 39% stake in Oberon. Stream it here on-demand. This week, the frontiers of fermentation. Today, we're joined by Angus Ballard, president of Lallemand Biofuels & Distilled Spirits as we explore a breakthrough in one-step yeast and enzymes. Fermentation king Joel Stone of the Due Diligence Wolfpack joins to independently assess the industry impact of this advance. Stream it here on-demand. Today, biocrude. Today my special guest is Ib Johannsen CEO of Bio2Oil - and we’re going to drop into the world of hydrothermal liquefaction and the opportunities in biocrude. And Steve Csonka of CAAFI joined in the lightning round. Stream it here on-demand. ESG financing. There’s 11.6 trillion in ESG finance. What can be done to ensure you get your share? We're joined by Cindy Thyfault and Gerard Ostheimer of Global Biofuture Solutions as we explored the tools, the must-dos, the must knows. We visited biobased mandates around the world. Where are the markets you can count on, how much can you count on? 65 countries in all, We’ll be focusing especially on new information out of the Americas, Asia and the EU. —In all, there’s more than 4 billion gallons of advanced biofuels capacity operating, under construction or planned, for the California market. What’s going on? To answer that question. we were joined by Dave Rubenstein the CEO of California Ethanol & Power, an advanced biofuels project based on sugarcane in the Imperial Valley, and Mark Riedy, the dean of renewable energy project finance and a partner at Kilpatrick Townsend Stockton. — Today we’re off in search of King Tech, which is to say, what technology or set of technologies is the perfect fit. We’re looking at a very special patch of ground near Ames in the great state of Iowa, It’s a great place to build stuff — more than 60 bioeconomy plants around the state To answer that question today we have the Due Diligence Wolfpack, fangs out, thirsty for value. They are the experts you’d hire to answer these very questions, but today we get to see how they think, how they fit technologies and feedstocks and infrastructuire in a feasible way. The Wolves are: Ron Cascone, David Dodds, James Iademarco, Michele Rubico, Joel Stone and Steve Weiss.. — Today we're joined by Clariant's Paolo Corvo with some great brand new video and updates on the Clariant first commercial cellulosic ethanol project in Romania, and the new licensee project in Bulgaria. And we're joined by AlgEternal CEO David Ramjohn on how algae technology fits into a circular bioeconomy.. Looking at 11 technologies, 21 projects and 13 emerging projects, plus market drivers and economics; with Emerging Markets CEO Will Thurmond and Digest editor Jim Lane . A Special Webinar: Opportunities in renewable fuels and chemicals at the Port of Rotterdam. In this special DIGEST WEBINAR, we look at the Port of Rotterdam for project opportunities in the advanced bioeconomy. We were joined by Stijn Effting, the Port's business manager for renewable fuels and chemicals.

Kalion Frequently Asked Questions (FAQ)

  • When was Kalion founded?

    Kalion was founded in 2010.

  • Where is Kalion's headquarters?

    Kalion's headquarters is located at 92 Elm Street, Milton.

  • What is Kalion's latest funding round?

    Kalion's latest funding round is Convertible Note - II.

  • How much did Kalion raise?

    Kalion raised a total of $7.06M.

  • Who are the investors of Kalion?

    Investors of Kalion include National Science Foundation, Cherrystone Angel Group, Golden Seeds and Launchpad Venture Group.

  • Who are Kalion's competitors?

    Competitors of Kalion include Solugen.

Compare Kalion to Competitors

AGAE Technologies

AGAE Technologies provides users with high-quality and high-purity RHAMNOLIPID biosurfactant products. The company specializes in the research, manufacturing and marketing of RHAMNOLIPID biosurfactants.

EnginZyme Logo

EnginZyme is a cell-free synthetic biology company that develops a technology platform that combines enzymatic cascades with packed bed reactors. The company provides research and developmental services to companies in multiple industries, such as pharma, food, chemicals, and flavors and fragrances. It was founded in 2014 and is based in Solna, Sweden.

Evolved by Nature Logo
Evolved by Nature

Evolved By Nature is a green chemistry company making consumer products healthier and more sustainable through the power of Activated Silk technology: pure, natural, liquid silk. Applications of the company's product are used in textiles, personal care, and medical uses. Evolved by Nature was founded in 2013 and is based in Medford, Massachusetts.

Geno Logo

Geno delivers manufacturing processes that enable its partners to produce intermediate and basic chemicals from renewable feedstocks. Its processes are designed to achieve better economics with enhanced sustainability and a smaller environmental footprint than petroleum-based manufacturing processes. The company was founded in 2000 and is based in San Diego, California.

Solugen Logo

​Solugen develops a specialty chemicals platform. It is a zero-carbon chemical producer that blends feedstock such as sugars, air, and carbon dioxide with genetically engineered enzymes to create alternatives to conventional chemicals. It serves industries such as agriculture, cleaning, water, energy, oil and gas, infrastructure, and more. The company was founded in 2016 and is based in Houston, Texas.

Arzeda Logo

Arzeda is a synthetic biology company that creates proteins, enzymes, and specialty chemicals for polymers, pharmaceuticals, industrial chemicals, and other advanced applications. It enables clients to access products that compete on performance, cost, and sustainability. The company was founded in 2007 and is based in Seattle, Washington.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.